HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eton Derma Labs paying $200,000 to settle FTC case involving Acne-Statin ad claims.

This article was originally published in The Rose Sheet

Executive Summary

ETON DERMA LABS TO PAY $200,000 IN ACNE STATIN SETTLEMENT WITH FTC involving charges by the Federal Trade Commission that ads claiming the Acne Statin kit is an effective treatment for severe or cystic acne are "deceptive" and not allowed under the OTC monograph for acne products. Under the proposed consent agreement, announced July 30, Eton Derma Labs and its principal, Atida Karr, will pay the civil penalty and refrain from using ads with the words "severe" or "cystic" acne. The firm also is prohibited from using photographs, videos or other depictions of individuals with cystic acne.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS003050

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel